New Triple-Drug cocktail targets tough pancreatic cancer
Disease control
Not yet recruiting
This early-stage study tests whether adding three drugs—ATRA, SDK002 (arsenic trioxide), and tislelizumab—to standard chemotherapy is safe for people with advanced pancreatic cancer that has spread or can't be removed. Ten participants will receive all treatments together, and re…
Phase: PHASE1 • Sponsor: Daniel Breadner • Aim: Disease control
Last updated May 11, 2026 20:39 UTC